Premium
Chronic urticaria – What does the new guideline tell us?
Author(s) -
Maurer Marcus,
Zuberbier Torsten,
Siebenhaar Frank,
Krause Karoline
Publication year - 2018
Publication title -
jddg: journal der deutschen dermatologischen gesellschaft
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 60
eISSN - 1610-0387
pISSN - 1610-0379
DOI - 10.1111/ddg.13531
Subject(s) - medicine , guideline , chronic urticaria , disease , intensive care medicine , chronic disease , therapeutic approach , spontaneous remission , disease treatment , physical therapy , pediatrics , dermatology , alternative medicine , pathology
Summary Patients with chronic urticaria experience significant impairment, and require an effective treatment. Such treatment is preceded by a thorough diagnostic workup and measurement of disease activity, disease burden and disease control using well‐established tools. Treatment is subsequently adjusted according to patient needs and therapeutic response, based on the tenet “as much as necessary, as little as possible” (in that order). Once disease control has been achieved, it is recommended that intermittent attempts at medication withdrawal be made in order to identify spontaneous disease remission. Chronic urticaria should be treated until spontaneous remission occurs.